Do cell phones increase brain cancer risk?

	Tweet

Philadelphia, 20 October 2008 – Major research initiatives are needed immediately to assess the possibility that using cellular phones may lead to an increased risk of brain tumors, according to an editorial in the November issue of the journal Surgical Neurology, published by Elsevier.

Recent studies have raised concerns that long-term exposure to electromagnetic fields (ELF) from cell-phone handsets can increase the risk of brain cancers and other nervous system tumors, according to the editorial by Dr. Ron Pawl, a neurosurgeon at Lake Forest Hospital, Lake Forest, Ill. He calls for collaborative research initiatives to determine whether the link between cell phones and brain cancer is real.

Scientists have long been concerned over the possibility that ELF exposure may increase the risk of brain cancers. Until recently, however, research has shown no clear link between cell phone use and brain tumors.

Earlier this year, a Swedish research group published an epidemiologic study suggesting an increased risk of brain cancers (gliomas) as well as acoustic nerve tumors (neuromas) in people using cell phones for ten years or longer. Tumors were more likely to develop on the same side as the cell phone was used. Other studies by the same group suggested that the use of wireless handsets in cordless home phones posed the same risk.

After reviewing the evidence, one author even suggested that long-term cell phone use is “more dangerous to health than smoking cigarettes.” Other recent commentators have raised similar concerns.

The findings are alarming in light of the exponential growth of cell phones—now including widespread use by children and teenagers. The damaging effects of ELF, if any, might be even greater in the developing brain.

If the link is real, then rates of brain cancers should have increased over the last two decades. Some studies have reported that this is the case, particularly for the most malignant brain cancers. However, other studies have found a stable tumor rate.

Some commentators have suggested that apparent increases in the number of brain cancers might reflect the use of sophisticated imaging techniques like computed tomography and magnetic resonance imaging. “However, the fact that the incidence of gliomas, especially the more malignant varieties, is increasing […] warrants action on this issue,” Dr. Pawl writes.

The problem, according to Dr. Pawl, is that no other research groups have performed actual studies showing a clear relationship between brain tumors and ELF. He calls on scientific societies to play a leading role in designing and conducting studies that will definitively determine the risks of brain cancer associated with ELF exposure, particularly from cell phones. “It seems that a cooperative effort by both the scientific community and state governing bodies will be needed,” writes Dr. Pawl. “Some spearhead is now necessary in view of the magnitude and seriousness of the situation.”

###

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier’s ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact: Maureen Hunter

215-239-3671
Elsevier

RELATED STORIES:
Researchers Identify Best Treatments for Long-Term Survival in Brain Tumor Patients   Cause and treatment for aggressive head and neck cancer may have been found   New treatment combination proves safe, effective for head and neck cancer patients   Evidence “increasingly against” phone cancer risk   WHO study has no clear answer on phones and cancer   Acupuncture Reduces Pain and Dysfunction in Head and Neck Cancer Patients After Neck Dissection   New technique holds promise for rare eye cancer   Disparities among patients with extremity soft-tissue sarcomas   Does Green Tea Prevent Cancer? Evidence Continues to Brew, But Questions Remain   Recurrent Brain Cancer Responds to New Treatment   Combining radiation therapy, chemotherapy safely treats head and neck cancer patients   BNCT, a new-generation radiation treatment, is effective in advanced head and neck cancer   Quality of life after treatment for head and neck cancer associated with longer-term survival   New Protocol Targets Aggressive Brain Cancer   Coffee may cut risk of head and neck cancers   New Imaging Analysis Predicts Brain Tumor Survival   Tobacco and alcohol use independently increase risk of head and neck cancer   Celldex brain cancer vaccine doubles survival   Study identifies 5 risk factors for late-stage head and neck cancer   Venom protein may lead to brain cancer cure   Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening   Study Finds Promising Chemoradiation Therapy

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]